Updated 10 March 2016

Action point


A monthly vaginal ring that contains an antiretroviral drug has been shown to cut the risk of HIV infection in women by nearly a third.

The long-acting ring was most effective in women over 25 who used it consistently and saw their risk of HIV drop by 61% while using the ring. It offers new hope for women who have multiple partners or whose partners are HIV positive.

We’ll keep you posted on when the ring becomes available to the general public.

Read more on preventing HIV infection.